158 related articles for article (PubMed ID: 22969924)
1. Von Willebrand factor, ADAMTS13 activity, TNF-α and their relationships in patients with chronic kidney disease.
Shen L; Lu G; Dong N; Jiang L; Ma Z; Ruan C
Exp Ther Med; 2012 Mar; 3(3):530-534. PubMed ID: 22969924
[TBL] [Abstract][Full Text] [Related]
2. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
[TBL] [Abstract][Full Text] [Related]
3. Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population.
Wang Z; Dou M; Du X; Ma L; Sun P; Cao H; Ye S; Jiang P; Liu F; Lin F; Zhang R; Li C
PeerJ; 2017; 5():e3156. PubMed ID: 28382235
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
[TBL] [Abstract][Full Text] [Related]
5. Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases.
Lu GY; Shen L; Wang ZY; Guo XF; Bai X; Su J; Ruan CG
Chin Med J (Engl); 2008 Jan; 121(2):133-6. PubMed ID: 18272039
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome.
Simbrunner B; Villesen IF; Scheiner B; Paternostro R; Schwabl P; Stättermayer AF; Marculescu R; Pinter M; Quehenberger P; Trauner M; Karsdal M; Lisman T; Reiberger T; Leeming DJ; Mandorfer M
Hepatol Int; 2023 Dec; 17(6):1532-1544. PubMed ID: 37605068
[TBL] [Abstract][Full Text] [Related]
7. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
[TBL] [Abstract][Full Text] [Related]
8. Von Willebrand Factor, ADAMTS13, and the Risk of Mortality: The Rotterdam Study.
Sonneveld MA; Franco OH; Ikram MA; Hofman A; Kavousi M; de Maat MP; Leebeek FW
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2446-2451. PubMed ID: 27737864
[TBL] [Abstract][Full Text] [Related]
9. Long-lasting prothrombotic state implied by changes of plasma von Willebrand factor parameters after radical prostatectomy for prostate malignancy.
Harsfalvi J; Molnar Z; Csanyi MC; Domjan I; Flasko T; Kaposi A; Benyo M
Urol Oncol; 2020 Apr; 38(4):191-197. PubMed ID: 31711834
[TBL] [Abstract][Full Text] [Related]
10. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
[TBL] [Abstract][Full Text] [Related]
11. Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia.
Ishikawa M; Uemura M; Matsuyama T; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Tsujimoto T; Takimura C; Fujimura Y; Fukui H
Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S25-33. PubMed ID: 19094193
[TBL] [Abstract][Full Text] [Related]
12. The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure.
Takaya H; Namisaki T; Enomoto M; Kubo T; Tsuji Y; Fujinaga Y; Nishimura N; Kaji K; Kawaratani H; Moriya K; Akahane T; Matsumoto M; Yoshiji H
Biology (Basel); 2023 Jan; 12(2):. PubMed ID: 36829443
[TBL] [Abstract][Full Text] [Related]
13. Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
Matsuyama T; Uemura M; Ishikawa M; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Takimura C; Fujimura Y; Fukui H
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S27-35. PubMed ID: 17331163
[TBL] [Abstract][Full Text] [Related]
14. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
15. Alteration of circulatory platelet microparticles and endothelial microparticles in patients with chronic kidney disease.
Lu GY; Xu RJ; Zhang SH; Qiao Q; Shen L; Li M; Xu DY; Wang ZY
Int J Clin Exp Med; 2015; 8(9):16704-8. PubMed ID: 26629207
[TBL] [Abstract][Full Text] [Related]
16. Platelet hyperaggregability is associated with decreased ADAMTS13 activity and enhanced endotoxemia in patients with acute cholangitis.
Takaya H; Kawaratani H; Kubo T; Seki K; Sawada Y; Kaji K; Okura Y; Takeda K; Kitade M; Moriya K; Namisaki T; Mitoro A; Matsumoto M; Fukui H; Yoshiji H
Hepatol Res; 2018 Feb; 48(3):E52-E60. PubMed ID: 28628948
[TBL] [Abstract][Full Text] [Related]
17. Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute-on-chronic liver failure development and prognosis in patients with liver cirrhosis.
Enomoto M; Takaya H; Namisaki T; Fujinaga Y; Nishimura N; Sawada Y; Kaji K; Kawaratani H; Moriya K; Akahane T; Inoue T; Matsumoto M; Yoshiji H
Hepatol Res; 2022 Apr; 52(4):390-400. PubMed ID: 34964539
[TBL] [Abstract][Full Text] [Related]
18. Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome.
Constantinescu-Bercu A; Kessler A; de Groot R; Dragunaite B; Heightman M; Hillman T; Price LC; Brennan E; Sivera R; Vanhoorelbeke K; Singh D; Scully M
J Thromb Haemost; 2023 Jan; 21(1):94-100. PubMed ID: 36695401
[TBL] [Abstract][Full Text] [Related]
19. ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease.
Demagny J; Driss A; Stepanian A; Anguel N; Affo L; Roux D; Habibi A; Benghezal S; Capdenat S; Coppo P; Driss F; Veyradier A
Res Pract Thromb Haemost; 2021 Jan; 5(1):197-203. PubMed ID: 33537544
[TBL] [Abstract][Full Text] [Related]
20. Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.
Domingueti CP; Dusse LM; Fóscolo RB; Reis JS; Annichino-Bizzacchi JM; Orsi FL; Mazetto Bde M; Carvalho Md; Gomes KB; Fernandes AP
PLoS One; 2015; 10(7):e0132784. PubMed ID: 26168189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
